nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Anagrelide—hematologic cancer	0.0511	0.0847	CbGbCtD
Rotigotine—CYP2D6—Lomustine—hematologic cancer	0.0271	0.045	CbGbCtD
Rotigotine—CYP1A2—Carmustine—hematologic cancer	0.0268	0.0445	CbGbCtD
Rotigotine—CYP2D6—Idarubicin—hematologic cancer	0.0242	0.0401	CbGbCtD
Rotigotine—CYP1A2—Methoxsalen—hematologic cancer	0.0228	0.0378	CbGbCtD
Rotigotine—CYP1A2—Bortezomib—hematologic cancer	0.0217	0.036	CbGbCtD
Rotigotine—CYP1A2—Daunorubicin—hematologic cancer	0.0208	0.0344	CbGbCtD
Rotigotine—CYP2D6—Hydroxyurea—hematologic cancer	0.0206	0.0341	CbGbCtD
Rotigotine—CYP1A2—Alitretinoin—hematologic cancer	0.0203	0.0337	CbGbCtD
Rotigotine—CYP1A2—Thalidomide—hematologic cancer	0.0189	0.0314	CbGbCtD
Rotigotine—CYP3A4—Bexarotene—hematologic cancer	0.0186	0.0308	CbGbCtD
Rotigotine—CYP2D6—Bortezomib—hematologic cancer	0.0179	0.0297	CbGbCtD
Rotigotine—CYP3A4—Busulfan—hematologic cancer	0.0173	0.0286	CbGbCtD
Rotigotine—CYP3A4—Lomustine—hematologic cancer	0.0173	0.0286	CbGbCtD
Rotigotine—CYP1A2—Dacarbazine—hematologic cancer	0.0163	0.027	CbGbCtD
Rotigotine—CYP1A2—Imatinib—hematologic cancer	0.0159	0.0264	CbGbCtD
Rotigotine—CYP3A4—Thiotepa—hematologic cancer	0.0154	0.0255	CbGbCtD
Rotigotine—CYP2D6—Imatinib—hematologic cancer	0.0131	0.0217	CbGbCtD
Rotigotine—CYP1A2—Dasatinib—hematologic cancer	0.0128	0.0212	CbGbCtD
Rotigotine—CYP3A4—Methoxsalen—hematologic cancer	0.012	0.0198	CbGbCtD
Rotigotine—CYP2D6—Nilotinib—hematologic cancer	0.0119	0.0197	CbGbCtD
Rotigotine—CYP2D6—Vinorelbine—hematologic cancer	0.0118	0.0196	CbGbCtD
Rotigotine—CYP3A4—Bortezomib—hematologic cancer	0.0114	0.0189	CbGbCtD
Rotigotine—CYP3A4—Daunorubicin—hematologic cancer	0.0109	0.018	CbGbCtD
Rotigotine—CYP3A4—Cytarabine—hematologic cancer	0.0096	0.0159	CbGbCtD
Rotigotine—CYP3A4—Teniposide—hematologic cancer	0.00945	0.0157	CbGbCtD
Rotigotine—CYP3A4—Ifosfamide—hematologic cancer	0.00872	0.0145	CbGbCtD
Rotigotine—CYP3A4—Imatinib—hematologic cancer	0.00833	0.0138	CbGbCtD
Rotigotine—CYP1A2—Etoposide—hematologic cancer	0.00796	0.0132	CbGbCtD
Rotigotine—CYP3A4—Ruxolitinib—hematologic cancer	0.00785	0.013	CbGbCtD
Rotigotine—CYP3A4—Nilotinib—hematologic cancer	0.00757	0.0126	CbGbCtD
Rotigotine—CYP3A4—Vinorelbine—hematologic cancer	0.00751	0.0125	CbGbCtD
Rotigotine—CYP2D6—Vinblastine—hematologic cancer	0.00728	0.0121	CbGbCtD
Rotigotine—CYP3A4—Triamcinolone—hematologic cancer	0.00687	0.0114	CbGbCtD
Rotigotine—CYP3A4—Dasatinib—hematologic cancer	0.00669	0.0111	CbGbCtD
Rotigotine—CYP3A4—Mitoxantrone—hematologic cancer	0.00661	0.011	CbGbCtD
Rotigotine—CYP3A4—Betamethasone—hematologic cancer	0.00589	0.00977	CbGbCtD
Rotigotine—CYP3A4—Prednisolone—hematologic cancer	0.00581	0.00964	CbGbCtD
Rotigotine—CYP3A4—Prednisone—hematologic cancer	0.00549	0.00911	CbGbCtD
Rotigotine—CYP2D6—Dexamethasone—hematologic cancer	0.00539	0.00894	CbGbCtD
Rotigotine—CYP3A4—Irinotecan—hematologic cancer	0.00521	0.00863	CbGbCtD
Rotigotine—CYP3A4—Vinblastine—hematologic cancer	0.00463	0.00767	CbGbCtD
Rotigotine—CYP3A4—Vincristine—hematologic cancer	0.00455	0.00754	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—hematologic cancer	0.00447	0.00742	CbGbCtD
Rotigotine—CYP3A4—Etoposide—hematologic cancer	0.00417	0.00691	CbGbCtD
Rotigotine—CYP3A4—Dexamethasone—hematologic cancer	0.00343	0.00568	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—hematologic cancer	0.00284	0.00472	CbGbCtD
Rotigotine—Headache—Irinotecan—hematologic cancer	5.31e-05	0.000172	CcSEcCtD
Rotigotine—Headache—Mitoxantrone—hematologic cancer	5.31e-05	0.000172	CcSEcCtD
Rotigotine—Nausea—Ifosfamide—hematologic cancer	5.3e-05	0.000172	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.29e-05	0.000172	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.29e-05	0.000172	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—hematologic cancer	5.27e-05	0.000171	CcSEcCtD
Rotigotine—Feeling abnormal—Triamcinolone—hematologic cancer	5.27e-05	0.000171	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—hematologic cancer	5.26e-05	0.000171	CcSEcCtD
Rotigotine—Vomiting—Gemcitabine—hematologic cancer	5.25e-05	0.00017	CcSEcCtD
Rotigotine—Insomnia—Betamethasone—hematologic cancer	5.25e-05	0.00017	CcSEcCtD
Rotigotine—Insomnia—Dexamethasone—hematologic cancer	5.25e-05	0.00017	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.23e-05	0.00017	CcSEcCtD
Rotigotine—Paraesthesia—Betamethasone—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Rotigotine—Paraesthesia—Dexamethasone—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Rotigotine—Discomfort—Prednisone—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Rotigotine—Rash—Gemcitabine—hematologic cancer	5.21e-05	0.000169	CcSEcCtD
Rotigotine—Dermatitis—Gemcitabine—hematologic cancer	5.2e-05	0.000169	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—hematologic cancer	5.19e-05	0.000169	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—hematologic cancer	5.19e-05	0.000168	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—hematologic cancer	5.17e-05	0.000168	CcSEcCtD
Rotigotine—Erythema—Methotrexate—hematologic cancer	5.17e-05	0.000168	CcSEcCtD
Rotigotine—Headache—Gemcitabine—hematologic cancer	5.17e-05	0.000168	CcSEcCtD
Rotigotine—Nausea—Vincristine—hematologic cancer	5.17e-05	0.000168	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisolone—hematologic cancer	5.12e-05	0.000166	CcSEcCtD
Rotigotine—Dyspepsia—Betamethasone—hematologic cancer	5.11e-05	0.000166	CcSEcCtD
Rotigotine—Dyspepsia—Dexamethasone—hematologic cancer	5.11e-05	0.000166	CcSEcCtD
Rotigotine—Urticaria—Triamcinolone—hematologic cancer	5.08e-05	0.000165	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—hematologic cancer	5.07e-05	0.000165	CcSEcCtD
Rotigotine—Asthenia—Etoposide—hematologic cancer	5.06e-05	0.000164	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—hematologic cancer	5.06e-05	0.000164	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—hematologic cancer	5.05e-05	0.000164	CcSEcCtD
Rotigotine—Decreased appetite—Dexamethasone—hematologic cancer	5.04e-05	0.000164	CcSEcCtD
Rotigotine—Decreased appetite—Betamethasone—hematologic cancer	5.04e-05	0.000164	CcSEcCtD
Rotigotine—Nausea—Mitoxantrone—hematologic cancer	5.03e-05	0.000163	CcSEcCtD
Rotigotine—Nausea—Irinotecan—hematologic cancer	5.03e-05	0.000163	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—hematologic cancer	5.02e-05	0.000163	CcSEcCtD
Rotigotine—Infection—Prednisone—hematologic cancer	5.02e-05	0.000163	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—hematologic cancer	5.01e-05	0.000163	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.01e-05	0.000163	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.01e-05	0.000163	CcSEcCtD
Rotigotine—Fatigue—Dexamethasone—hematologic cancer	5e-05	0.000162	CcSEcCtD
Rotigotine—Fatigue—Betamethasone—hematologic cancer	5e-05	0.000162	CcSEcCtD
Rotigotine—Pruritus—Etoposide—hematologic cancer	4.99e-05	0.000162	CcSEcCtD
Rotigotine—Shock—Prednisone—hematologic cancer	4.97e-05	0.000161	CcSEcCtD
Rotigotine—Pain—Dexamethasone—hematologic cancer	4.96e-05	0.000161	CcSEcCtD
Rotigotine—Pain—Betamethasone—hematologic cancer	4.96e-05	0.000161	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—hematologic cancer	4.96e-05	0.000161	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—hematologic cancer	4.95e-05	0.000161	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—hematologic cancer	4.91e-05	0.000159	CcSEcCtD
Rotigotine—Nausea—Gemcitabine—hematologic cancer	4.9e-05	0.000159	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—hematologic cancer	4.89e-05	0.000159	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisone—hematologic cancer	4.88e-05	0.000159	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—hematologic cancer	4.87e-05	0.000158	CcSEcCtD
Rotigotine—Rash—Cisplatin—hematologic cancer	4.85e-05	0.000157	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—hematologic cancer	4.85e-05	0.000157	CcSEcCtD
Rotigotine—Erythema—Epirubicin—hematologic cancer	4.84e-05	0.000157	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—hematologic cancer	4.84e-05	0.000157	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—hematologic cancer	4.82e-05	0.000157	CcSEcCtD
Rotigotine—Anorexia—Prednisone—hematologic cancer	4.82e-05	0.000156	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—hematologic cancer	4.8e-05	0.000156	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—hematologic cancer	4.8e-05	0.000156	CcSEcCtD
Rotigotine—Feeling abnormal—Dexamethasone—hematologic cancer	4.78e-05	0.000155	CcSEcCtD
Rotigotine—Feeling abnormal—Betamethasone—hematologic cancer	4.78e-05	0.000155	CcSEcCtD
Rotigotine—Hypersensitivity—Triamcinolone—hematologic cancer	4.71e-05	0.000153	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—hematologic cancer	4.67e-05	0.000152	CcSEcCtD
Rotigotine—Malaise—Methotrexate—hematologic cancer	4.67e-05	0.000151	CcSEcCtD
Rotigotine—Dizziness—Etoposide—hematologic cancer	4.66e-05	0.000151	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—hematologic cancer	4.65e-05	0.000151	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—hematologic cancer	4.65e-05	0.000151	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—hematologic cancer	4.65e-05	0.000151	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—hematologic cancer	4.64e-05	0.000151	CcSEcCtD
Rotigotine—Urticaria—Dexamethasone—hematologic cancer	4.61e-05	0.00015	CcSEcCtD
Rotigotine—Urticaria—Betamethasone—hematologic cancer	4.61e-05	0.00015	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.6e-05	0.000149	CcSEcCtD
Rotigotine—Dizziness—Prednisolone—hematologic cancer	4.6e-05	0.000149	CcSEcCtD
Rotigotine—Asthenia—Triamcinolone—hematologic cancer	4.59e-05	0.000149	CcSEcCtD
Rotigotine—Nausea—Cisplatin—hematologic cancer	4.57e-05	0.000148	CcSEcCtD
Rotigotine—Insomnia—Prednisone—hematologic cancer	4.57e-05	0.000148	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—hematologic cancer	4.54e-05	0.000147	CcSEcCtD
Rotigotine—Pruritus—Triamcinolone—hematologic cancer	4.52e-05	0.000147	CcSEcCtD
Rotigotine—Cough—Methotrexate—hematologic cancer	4.51e-05	0.000147	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—hematologic cancer	4.51e-05	0.000146	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—hematologic cancer	4.49e-05	0.000146	CcSEcCtD
Rotigotine—Vomiting—Etoposide—hematologic cancer	4.48e-05	0.000145	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—hematologic cancer	4.48e-05	0.000145	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—hematologic cancer	4.48e-05	0.000145	CcSEcCtD
Rotigotine—Agitation—Epirubicin—hematologic cancer	4.45e-05	0.000144	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—hematologic cancer	4.45e-05	0.000144	CcSEcCtD
Rotigotine—Rash—Etoposide—hematologic cancer	4.44e-05	0.000144	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—hematologic cancer	4.44e-05	0.000144	CcSEcCtD
Rotigotine—Headache—Etoposide—hematologic cancer	4.42e-05	0.000143	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—hematologic cancer	4.4e-05	0.000143	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—hematologic cancer	4.39e-05	0.000143	CcSEcCtD
Rotigotine—Rash—Prednisolone—hematologic cancer	4.38e-05	0.000142	CcSEcCtD
Rotigotine—Dermatitis—Prednisolone—hematologic cancer	4.38e-05	0.000142	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.37e-05	0.000142	CcSEcCtD
Rotigotine—Malaise—Epirubicin—hematologic cancer	4.37e-05	0.000142	CcSEcCtD
Rotigotine—Fatigue—Prednisone—hematologic cancer	4.36e-05	0.000141	CcSEcCtD
Rotigotine—Headache—Prednisolone—hematologic cancer	4.36e-05	0.000141	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—hematologic cancer	4.35e-05	0.000141	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—hematologic cancer	4.35e-05	0.000141	CcSEcCtD
Rotigotine—Syncope—Epirubicin—hematologic cancer	4.34e-05	0.000141	CcSEcCtD
Rotigotine—Constipation—Prednisone—hematologic cancer	4.32e-05	0.00014	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—hematologic cancer	4.31e-05	0.00014	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—hematologic cancer	4.26e-05	0.000138	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—hematologic cancer	4.26e-05	0.000138	CcSEcCtD
Rotigotine—Dizziness—Triamcinolone—hematologic cancer	4.23e-05	0.000137	CcSEcCtD
Rotigotine—Cough—Epirubicin—hematologic cancer	4.22e-05	0.000137	CcSEcCtD
Rotigotine—Infection—Methotrexate—hematologic cancer	4.19e-05	0.000136	CcSEcCtD
Rotigotine—Nausea—Etoposide—hematologic cancer	4.19e-05	0.000136	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—hematologic cancer	4.18e-05	0.000136	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—hematologic cancer	4.16e-05	0.000135	CcSEcCtD
Rotigotine—Asthenia—Betamethasone—hematologic cancer	4.16e-05	0.000135	CcSEcCtD
Rotigotine—Asthenia—Dexamethasone—hematologic cancer	4.16e-05	0.000135	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—hematologic cancer	4.16e-05	0.000135	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—hematologic cancer	4.14e-05	0.000134	CcSEcCtD
Rotigotine—Nausea—Prednisolone—hematologic cancer	4.13e-05	0.000134	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—hematologic cancer	4.12e-05	0.000134	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—hematologic cancer	4.12e-05	0.000134	CcSEcCtD
Rotigotine—Pruritus—Betamethasone—hematologic cancer	4.1e-05	0.000133	CcSEcCtD
Rotigotine—Pruritus—Dexamethasone—hematologic cancer	4.1e-05	0.000133	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—hematologic cancer	4.1e-05	0.000133	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.09e-05	0.000133	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—hematologic cancer	4.08e-05	0.000132	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—hematologic cancer	4.07e-05	0.000132	CcSEcCtD
Rotigotine—Vomiting—Triamcinolone—hematologic cancer	4.07e-05	0.000132	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—hematologic cancer	4.04e-05	0.000131	CcSEcCtD
Rotigotine—Rash—Triamcinolone—hematologic cancer	4.03e-05	0.000131	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—hematologic cancer	4.03e-05	0.000131	CcSEcCtD
Rotigotine—Dermatitis—Triamcinolone—hematologic cancer	4.03e-05	0.000131	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—hematologic cancer	4.02e-05	0.000131	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—hematologic cancer	4.02e-05	0.000131	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—hematologic cancer	4.02e-05	0.00013	CcSEcCtD
Rotigotine—Urticaria—Prednisone—hematologic cancer	4.01e-05	0.00013	CcSEcCtD
Rotigotine—Headache—Triamcinolone—hematologic cancer	4.01e-05	0.00013	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—hematologic cancer	3.98e-05	0.000129	CcSEcCtD
Rotigotine—Diarrhoea—Dexamethasone—hematologic cancer	3.97e-05	0.000129	CcSEcCtD
Rotigotine—Diarrhoea—Betamethasone—hematologic cancer	3.97e-05	0.000129	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—hematologic cancer	3.95e-05	0.000128	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—hematologic cancer	3.94e-05	0.000128	CcSEcCtD
Rotigotine—Infection—Epirubicin—hematologic cancer	3.93e-05	0.000127	CcSEcCtD
Rotigotine—Cough—Doxorubicin—hematologic cancer	3.91e-05	0.000127	CcSEcCtD
Rotigotine—Shock—Epirubicin—hematologic cancer	3.89e-05	0.000126	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—hematologic cancer	3.88e-05	0.000126	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—hematologic cancer	3.87e-05	0.000126	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.85e-05	0.000125	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—hematologic cancer	3.84e-05	0.000125	CcSEcCtD
Rotigotine—Dizziness—Betamethasone—hematologic cancer	3.84e-05	0.000125	CcSEcCtD
Rotigotine—Dizziness—Dexamethasone—hematologic cancer	3.84e-05	0.000125	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—hematologic cancer	3.82e-05	0.000124	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—hematologic cancer	3.82e-05	0.000124	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—hematologic cancer	3.81e-05	0.000124	CcSEcCtD
Rotigotine—Nausea—Triamcinolone—hematologic cancer	3.8e-05	0.000123	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—hematologic cancer	3.79e-05	0.000123	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.79e-05	0.000123	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—hematologic cancer	3.77e-05	0.000122	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—hematologic cancer	3.77e-05	0.000122	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—hematologic cancer	3.75e-05	0.000122	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—hematologic cancer	3.73e-05	0.000121	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—hematologic cancer	3.72e-05	0.000121	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—hematologic cancer	3.72e-05	0.000121	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—hematologic cancer	3.69e-05	0.00012	CcSEcCtD
Rotigotine—Vomiting—Betamethasone—hematologic cancer	3.69e-05	0.00012	CcSEcCtD
Rotigotine—Vomiting—Dexamethasone—hematologic cancer	3.69e-05	0.00012	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—hematologic cancer	3.69e-05	0.00012	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—hematologic cancer	3.67e-05	0.000119	CcSEcCtD
Rotigotine—Rash—Dexamethasone—hematologic cancer	3.66e-05	0.000119	CcSEcCtD
Rotigotine—Rash—Betamethasone—hematologic cancer	3.66e-05	0.000119	CcSEcCtD
Rotigotine—Dermatitis—Betamethasone—hematologic cancer	3.65e-05	0.000119	CcSEcCtD
Rotigotine—Dermatitis—Dexamethasone—hematologic cancer	3.65e-05	0.000119	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.65e-05	0.000118	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—hematologic cancer	3.64e-05	0.000118	CcSEcCtD
Rotigotine—Headache—Betamethasone—hematologic cancer	3.63e-05	0.000118	CcSEcCtD
Rotigotine—Headache—Dexamethasone—hematologic cancer	3.63e-05	0.000118	CcSEcCtD
Rotigotine—Infection—Doxorubicin—hematologic cancer	3.63e-05	0.000118	CcSEcCtD
Rotigotine—Asthenia—Prednisone—hematologic cancer	3.62e-05	0.000118	CcSEcCtD
Rotigotine—Pain—Methotrexate—hematologic cancer	3.61e-05	0.000117	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.6e-05	0.000117	CcSEcCtD
Rotigotine—Shock—Doxorubicin—hematologic cancer	3.6e-05	0.000117	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—hematologic cancer	3.59e-05	0.000116	CcSEcCtD
Rotigotine—Pruritus—Prednisone—hematologic cancer	3.57e-05	0.000116	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—hematologic cancer	3.57e-05	0.000116	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—hematologic cancer	3.55e-05	0.000115	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—hematologic cancer	3.55e-05	0.000115	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.53e-05	0.000115	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—hematologic cancer	3.51e-05	0.000114	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—hematologic cancer	3.49e-05	0.000113	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—hematologic cancer	3.48e-05	0.000113	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—hematologic cancer	3.48e-05	0.000113	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—hematologic cancer	3.46e-05	0.000112	CcSEcCtD
Rotigotine—Nausea—Betamethasone—hematologic cancer	3.45e-05	0.000112	CcSEcCtD
Rotigotine—Nausea—Dexamethasone—hematologic cancer	3.45e-05	0.000112	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—hematologic cancer	3.43e-05	0.000111	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—hematologic cancer	3.42e-05	0.000111	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.41e-05	0.000111	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—hematologic cancer	3.41e-05	0.000111	CcSEcCtD
Rotigotine—Pain—Epirubicin—hematologic cancer	3.38e-05	0.00011	CcSEcCtD
Rotigotine—Constipation—Epirubicin—hematologic cancer	3.38e-05	0.00011	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—hematologic cancer	3.35e-05	0.000109	CcSEcCtD
Rotigotine—Dizziness—Prednisone—hematologic cancer	3.34e-05	0.000108	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.33e-05	0.000108	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—hematologic cancer	3.31e-05	0.000107	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—hematologic cancer	3.28e-05	0.000107	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—hematologic cancer	3.26e-05	0.000106	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—hematologic cancer	3.25e-05	0.000105	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—hematologic cancer	3.22e-05	0.000104	CcSEcCtD
Rotigotine—Vomiting—Prednisone—hematologic cancer	3.21e-05	0.000104	CcSEcCtD
Rotigotine—Rash—Prednisone—hematologic cancer	3.19e-05	0.000103	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—hematologic cancer	3.18e-05	0.000103	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—hematologic cancer	3.18e-05	0.000103	CcSEcCtD
Rotigotine—Headache—Prednisone—hematologic cancer	3.17e-05	0.000103	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.16e-05	0.000102	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—hematologic cancer	3.15e-05	0.000102	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—hematologic cancer	3.14e-05	0.000102	CcSEcCtD
Rotigotine—Pain—Doxorubicin—hematologic cancer	3.13e-05	0.000101	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—hematologic cancer	3.13e-05	0.000101	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—hematologic cancer	3.11e-05	0.000101	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—hematologic cancer	3.03e-05	9.83e-05	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—hematologic cancer	3.01e-05	9.78e-05	CcSEcCtD
Rotigotine—Nausea—Prednisone—hematologic cancer	3e-05	9.74e-05	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—hematologic cancer	2.99e-05	9.69e-05	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—hematologic cancer	2.91e-05	9.45e-05	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—hematologic cancer	2.9e-05	9.43e-05	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—hematologic cancer	2.89e-05	9.38e-05	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—hematologic cancer	2.84e-05	9.2e-05	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—hematologic cancer	2.8e-05	9.07e-05	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—hematologic cancer	2.79e-05	9.06e-05	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—hematologic cancer	2.7e-05	8.77e-05	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—hematologic cancer	2.69e-05	8.74e-05	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—hematologic cancer	2.68e-05	8.71e-05	CcSEcCtD
Rotigotine—Rash—Methotrexate—hematologic cancer	2.66e-05	8.64e-05	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—hematologic cancer	2.66e-05	8.63e-05	CcSEcCtD
Rotigotine—Headache—Methotrexate—hematologic cancer	2.65e-05	8.58e-05	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—hematologic cancer	2.62e-05	8.51e-05	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—hematologic cancer	2.61e-05	8.48e-05	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—hematologic cancer	2.59e-05	8.39e-05	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—hematologic cancer	2.51e-05	8.15e-05	CcSEcCtD
Rotigotine—Nausea—Methotrexate—hematologic cancer	2.51e-05	8.14e-05	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—hematologic cancer	2.5e-05	8.12e-05	CcSEcCtD
Rotigotine—Rash—Epirubicin—hematologic cancer	2.49e-05	8.09e-05	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—hematologic cancer	2.49e-05	8.08e-05	CcSEcCtD
Rotigotine—Headache—Epirubicin—hematologic cancer	2.48e-05	8.03e-05	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—hematologic cancer	2.42e-05	7.85e-05	CcSEcCtD
Rotigotine—Nausea—Epirubicin—hematologic cancer	2.35e-05	7.62e-05	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—hematologic cancer	2.32e-05	7.54e-05	CcSEcCtD
Rotigotine—Rash—Doxorubicin—hematologic cancer	2.31e-05	7.48e-05	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—hematologic cancer	2.3e-05	7.47e-05	CcSEcCtD
Rotigotine—Headache—Doxorubicin—hematologic cancer	2.29e-05	7.43e-05	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—hematologic cancer	2.17e-05	7.05e-05	CcSEcCtD
Rotigotine—DRD2—Signaling Pathways—CD80—hematologic cancer	5.09e-06	5.73e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MTOR—hematologic cancer	5.09e-06	5.73e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CB—hematologic cancer	5.09e-06	5.73e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	5.09e-06	5.73e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	5.08e-06	5.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KIT—hematologic cancer	5.08e-06	5.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NRAS—hematologic cancer	5.08e-06	5.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.05e-06	5.69e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGF2—hematologic cancer	5.04e-06	5.68e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	5.04e-06	5.67e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYCS—hematologic cancer	4.99e-06	5.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTPN11—hematologic cancer	4.99e-06	5.62e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	4.98e-06	5.61e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3R1—hematologic cancer	4.97e-06	5.6e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—hematologic cancer	4.96e-06	5.58e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.96e-06	5.58e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—hematologic cancer	4.95e-06	5.57e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—hematologic cancer	4.92e-06	5.54e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.92e-06	5.53e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.9e-06	5.51e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGF2—hematologic cancer	4.87e-06	5.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	4.86e-06	5.48e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—hematologic cancer	4.86e-06	5.47e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK8—hematologic cancer	4.84e-06	5.45e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1B—hematologic cancer	4.84e-06	5.45e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JAK2—hematologic cancer	4.83e-06	5.44e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREB1—hematologic cancer	4.83e-06	5.44e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—hematologic cancer	4.83e-06	5.43e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	4.8e-06	5.41e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.79e-06	5.39e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—hematologic cancer	4.79e-06	5.39e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—hematologic cancer	4.77e-06	5.37e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	4.77e-06	5.37e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.77e-06	5.37e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.77e-06	5.37e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—hematologic cancer	4.74e-06	5.34e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—hematologic cancer	4.74e-06	5.33e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—hematologic cancer	4.73e-06	5.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL2—hematologic cancer	4.73e-06	5.33e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—hematologic cancer	4.73e-06	5.32e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	4.72e-06	5.32e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MDM2—hematologic cancer	4.72e-06	5.31e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—hematologic cancer	4.72e-06	5.31e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6R—hematologic cancer	4.72e-06	5.31e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—hematologic cancer	4.71e-06	5.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	4.71e-06	5.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—hematologic cancer	4.68e-06	5.27e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—hematologic cancer	4.67e-06	5.26e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JAK2—hematologic cancer	4.67e-06	5.25e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—hematologic cancer	4.65e-06	5.23e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—hematologic cancer	4.62e-06	5.2e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—hematologic cancer	4.61e-06	5.18e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—hematologic cancer	4.59e-06	5.17e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—hematologic cancer	4.59e-06	5.17e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—hematologic cancer	4.59e-06	5.17e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—hematologic cancer	4.58e-06	5.15e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	4.57e-06	5.15e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—hematologic cancer	4.56e-06	5.13e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—hematologic cancer	4.55e-06	5.13e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—hematologic cancer	4.54e-06	5.12e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	4.49e-06	5.06e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—hematologic cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	4.47e-06	5.03e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—hematologic cancer	4.46e-06	5.03e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.46e-06	5.02e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—hematologic cancer	4.45e-06	5.01e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	4.43e-06	4.99e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—hematologic cancer	4.43e-06	4.99e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—hematologic cancer	4.43e-06	4.98e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.42e-06	4.98e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—hematologic cancer	4.41e-06	4.97e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	4.41e-06	4.96e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—hematologic cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—hematologic cancer	4.38e-06	4.94e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—hematologic cancer	4.38e-06	4.93e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	4.37e-06	4.92e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK8—hematologic cancer	4.36e-06	4.91e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—hematologic cancer	4.35e-06	4.89e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1B—hematologic cancer	4.31e-06	4.85e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK8—hematologic cancer	4.3e-06	4.84e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—hematologic cancer	4.29e-06	4.83e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGF2—hematologic cancer	4.28e-06	4.81e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—hematologic cancer	4.26e-06	4.8e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.26e-06	4.79e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—hematologic cancer	4.25e-06	4.78e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	4.23e-06	4.76e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—hematologic cancer	4.23e-06	4.76e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—hematologic cancer	4.22e-06	4.75e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.22e-06	4.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—hematologic cancer	4.22e-06	4.75e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	4.22e-06	4.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—hematologic cancer	4.2e-06	4.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—hematologic cancer	4.19e-06	4.72e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—hematologic cancer	4.19e-06	4.71e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.16e-06	4.69e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	4.16e-06	4.68e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—hematologic cancer	4.13e-06	4.65e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	4.12e-06	4.63e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—hematologic cancer	4.11e-06	4.63e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—hematologic cancer	4.11e-06	4.63e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—hematologic cancer	4.1e-06	4.62e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—hematologic cancer	4.1e-06	4.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JAK2—hematologic cancer	4.1e-06	4.61e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—hematologic cancer	4.08e-06	4.59e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—hematologic cancer	4.08e-06	4.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—hematologic cancer	4.07e-06	4.58e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.07e-06	4.58e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CD44—hematologic cancer	4.07e-06	4.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—hematologic cancer	4.05e-06	4.56e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.04e-06	4.55e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.04e-06	4.55e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—hematologic cancer	4.02e-06	4.53e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	4.02e-06	4.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—hematologic cancer	4e-06	4.5e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—hematologic cancer	3.98e-06	4.48e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—hematologic cancer	3.98e-06	4.48e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—hematologic cancer	3.97e-06	4.47e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—hematologic cancer	3.97e-06	4.47e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—hematologic cancer	3.97e-06	4.47e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—hematologic cancer	3.97e-06	4.47e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—hematologic cancer	3.96e-06	4.46e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—hematologic cancer	3.93e-06	4.43e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—hematologic cancer	3.92e-06	4.41e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—hematologic cancer	3.89e-06	4.38e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	3.89e-06	4.38e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK8—hematologic cancer	3.88e-06	4.37e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—hematologic cancer	3.87e-06	4.36e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—hematologic cancer	3.86e-06	4.35e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.85e-06	4.34e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	3.84e-06	4.32e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	3.83e-06	4.31e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.83e-06	4.31e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—hematologic cancer	3.81e-06	4.28e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—hematologic cancer	3.8e-06	4.28e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—hematologic cancer	3.78e-06	4.26e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—hematologic cancer	3.76e-06	4.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	3.75e-06	4.22e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	3.74e-06	4.21e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	3.72e-06	4.18e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—hematologic cancer	3.7e-06	4.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—hematologic cancer	3.69e-06	4.16e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—hematologic cancer	3.68e-06	4.14e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—hematologic cancer	3.65e-06	4.11e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—hematologic cancer	3.65e-06	4.11e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	3.65e-06	4.11e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—hematologic cancer	3.64e-06	4.1e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	3.61e-06	4.07e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—hematologic cancer	3.58e-06	4.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—hematologic cancer	3.58e-06	4.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—hematologic cancer	3.57e-06	4.02e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.57e-06	4.02e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—hematologic cancer	3.56e-06	4e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—hematologic cancer	3.55e-06	4e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—hematologic cancer	3.55e-06	4e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.54e-06	3.99e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—hematologic cancer	3.54e-06	3.99e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—hematologic cancer	3.49e-06	3.93e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—hematologic cancer	3.48e-06	3.92e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—hematologic cancer	3.48e-06	3.91e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	3.46e-06	3.89e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	3.43e-06	3.86e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—hematologic cancer	3.42e-06	3.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	3.42e-06	3.85e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.4e-06	3.82e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—hematologic cancer	3.39e-06	3.82e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—hematologic cancer	3.38e-06	3.8e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—hematologic cancer	3.37e-06	3.8e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	3.37e-06	3.79e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—hematologic cancer	3.36e-06	3.79e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	3.3e-06	3.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	3.29e-06	3.7e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	3.29e-06	3.7e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.29e-06	3.7e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	3.28e-06	3.69e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	3.27e-06	3.68e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—hematologic cancer	3.23e-06	3.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.21e-06	3.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—hematologic cancer	3.21e-06	3.61e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—hematologic cancer	3.18e-06	3.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	3.18e-06	3.57e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.15e-06	3.54e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.14e-06	3.54e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.12e-06	3.51e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.12e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—hematologic cancer	3.12e-06	3.51e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.11e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	3.1e-06	3.49e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—hematologic cancer	3.09e-06	3.48e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—hematologic cancer	3.07e-06	3.46e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	3.05e-06	3.43e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—hematologic cancer	3.04e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	3.04e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—hematologic cancer	3.01e-06	3.39e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3e-06	3.38e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—hematologic cancer	3e-06	3.38e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—hematologic cancer	3e-06	3.38e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.94e-06	3.31e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.94e-06	3.31e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—hematologic cancer	2.91e-06	3.27e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.87e-06	3.24e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—hematologic cancer	2.87e-06	3.23e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—hematologic cancer	2.85e-06	3.21e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	2.8e-06	3.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—hematologic cancer	2.79e-06	3.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	2.79e-06	3.14e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.78e-06	3.13e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—hematologic cancer	2.78e-06	3.13e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.76e-06	3.1e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—hematologic cancer	2.75e-06	3.09e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.72e-06	3.06e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	2.71e-06	3.05e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	2.7e-06	3.04e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.64e-06	2.97e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.61e-06	2.94e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—hematologic cancer	2.6e-06	2.93e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	2.59e-06	2.92e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—hematologic cancer	2.58e-06	2.91e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—hematologic cancer	2.57e-06	2.89e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—hematologic cancer	2.53e-06	2.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.5e-06	2.81e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.49e-06	2.81e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	2.48e-06	2.79e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—hematologic cancer	2.39e-06	2.69e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	2.37e-06	2.67e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.35e-06	2.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.32e-06	2.61e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.3e-06	2.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—hematologic cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	2.29e-06	2.57e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—hematologic cancer	2.24e-06	2.52e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	2.21e-06	2.49e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—hematologic cancer	2.2e-06	2.47e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.15e-06	2.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—hematologic cancer	2.1e-06	2.37e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.04e-06	2.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—hematologic cancer	2.01e-06	2.26e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.99e-06	2.24e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.94e-06	2.18e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.92e-06	2.16e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—hematologic cancer	1.9e-06	2.13e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.78e-06	2e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.66e-06	1.86e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.53e-06	1.73e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—hematologic cancer	1.46e-06	1.65e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.58e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.35e-06	1.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.15e-06	1.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.22e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.84e-07	9.95e-06	CbGpPWpGaD
